Here's a link to an article discussing a dispute related to the patent on HPV vaccine:
http://www.biox.cn/content/20060407/43284.htm
I can't work out whether this represents a threat to CSL's potential licensing revenue from Gardasil.
Does anyone out there with a background in IP and specific knowledge of this patent dispute have a comment?
patent problem
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$277.01 |
Change
-7.040(2.48%) |
Mkt cap ! $134.1B | |||
| Open | High | Low | Value | Volume |
| $280.67 | $281.07 | $275.01 | $254.8M | 915.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1140 | $277.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $277.08 | 312 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |